Table 4.
Patient | Age, Gender |
Lesion | Days Since Onset | BS | SIAS | FMA-UE | MAS | Affected Side |
---|---|---|---|---|---|---|---|---|
HGR-001 | 80, M | CI | 11 | 5, 5 | 4, 4 | 58 | 0, 0, 0 | R |
HGR-002 | 32, F | CI | 11 | 5, 5 | 4, 4 | 50 | 0, 0, 0 | R |
HGR-003 | 71, M | ICH | 13 | 5, 5 | 4, 4 | 64 | 1, 0, 0 | R |
HGR-004 | 52, F | CI | 8 | 6, 6 | 5, 5 | 63 | 0, 0, 0 | L |
HGR-005 | 82, M | CI | 9 | 4, 3 | 3, 1 | 27 | 1, 0, 0 | L |
HGR-006 | 81, M | ICH | 5 | 2, 4 | 1, 1 | 16 | 0, 0, 0 | R |
HGR-007 | 77, M | CI | 9 | 6, 6 | 5, 5 | 60 | 0, 0, 0 | R |
HGR-008 | 79, F | ICH | 7 | 3, 4 | 2, 3 | 28 | 0, 1+, 1+ | R |
HGR-009 | 65, M | ICH | 5 | 6, 6 | 5, 5 | 55 | 0, 0, 0 | R |
HGR-010 | 67, F | ICH | 12 | 5, 4 | 3, 1 | 37 | 0, 0, 0 | L |
HGR-011 | 66, M | CI | 13 | 3, 3 | 2, 1 | 15 | 1+, 0, 0 | L |
HGR-012 | 64, F | ICH | 33 | 4, 5 | 3, 4 | 35 | 1, 1, 0 | L |
HGR-013 | 63, M | CI | 13 | 5, 5 | 4, 4 | 59 | 1, 0, 0 | R |
HGR-014 | 50, M | CI | 19 | 3, 3 | 2, 1 | 22 | 1, 1, 0 | R |
HGR-015 | 72, F | CI | 16 | 6, 5 | 5, 4 | 52 | 0, 0, 0 | R |
HGR-016 | 57, M | ICH | 12 | 5, 4 | 4, 4 | 42 | 0, 0, 0 | L |
HGR-017 | 57, M | ICH | 18 | 2, 2 | 1, 0 | 8 | 0, 0, 0 | L |
HGR-018 | 64, M | CI | 9 | 6, 6 | 4, 4 | 60 | 0, 0, 0 | R |
HGR-019 | 74, F | CI | 12 | 2, 1 | 1, 0 | 9 | 0, 1, 0 | L |
‘+’ in the MAS column indicates spasticity progression. MAS evaluates only the affected upper extremities; it has triple parameters which represent the spasticity of the elbow, wrist, and fingers. BS and SIAS have binary parameters which represent the forearm and hand.